Neola Medical AB (publ) (STO:NEOLA)
Sweden
· Delayed Price · Currency is SEK 0.880
0.00 (0.00%)
Mar 5, 2026, 4:26 PM CET
Neola Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Operating Revenue | 8.28 | 10.07 | 9.78 | 9.44 | 10.38 | Upgrade
|
| Other Revenue | - | 0.05 | 0.04 | 0.3 | 0.74 | Upgrade
|
| Revenue | 8.28 | 10.12 | 9.83 | 9.74 | 11.13 | Upgrade
|
| Revenue Growth (YoY) | -18.13% | 2.97% | 0.84% | -12.43% | 280.64% | Upgrade
|
| Cost of Revenue | 0.27 | 1.37 | 1.77 | 1.42 | 1.33 | Upgrade
|
| Gross Profit | 8.01 | 8.75 | 8.06 | 8.32 | 9.8 | Upgrade
|
| Selling, General & Admin | 17.76 | 18.23 | 16.09 | 17.64 | 16.39 | Upgrade
|
| Other Operating Expenses | -0.05 | -0.21 | - | 0.03 | 0.04 | Upgrade
|
| Operating Expenses | 19.1 | 19.55 | 17.69 | 18.44 | 16.45 | Upgrade
|
| Operating Income | -11.09 | -10.8 | -9.63 | -10.12 | -6.65 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.73 | 0.61 | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | -11.02 | -10.06 | -9.01 | -10.09 | -6.65 | Upgrade
|
| Asset Writedown | - | - | - | -0.27 | - | Upgrade
|
| Pretax Income | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 | Upgrade
|
| Net Income | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 | Upgrade
|
| Net Income to Common | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 | Upgrade
|
| Shares Outstanding (Basic) | 77 | 70 | 56 | 26 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 70 | 56 | 26 | 14 | Upgrade
|
| Shares Change (YoY) | 9.27% | 25.80% | 113.90% | 86.03% | 48.67% | Upgrade
|
| EPS (Basic) | -0.14 | -0.14 | -0.16 | -0.40 | -0.47 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.14 | -0.16 | -0.40 | -0.47 | Upgrade
|
| Free Cash Flow | -11.95 | -10.92 | -6.54 | -8.6 | -7.1 | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.16 | -0.12 | -0.33 | -0.51 | Upgrade
|
| Gross Margin | 96.69% | 86.47% | 82.04% | 85.41% | 88.05% | Upgrade
|
| Operating Margin | -133.93% | -106.73% | -97.97% | -103.86% | -59.80% | Upgrade
|
| Profit Margin | -133.07% | -99.48% | -91.70% | -106.26% | -59.80% | Upgrade
|
| Free Cash Flow Margin | -144.30% | -107.90% | -66.59% | -88.27% | -63.83% | Upgrade
|
| EBITDA | -9.71 | -9.4 | -8.19 | -9.55 | -6.64 | Upgrade
|
| EBITDA Margin | -117.20% | -92.95% | -83.39% | -98.00% | -59.66% | Upgrade
|
| D&A For EBITDA | 1.39 | 1.39 | 1.43 | 0.57 | 0.02 | Upgrade
|
| EBIT | -11.09 | -10.8 | -9.63 | -10.12 | -6.65 | Upgrade
|
| EBIT Margin | -133.93% | -106.73% | -97.97% | -103.86% | -59.80% | Upgrade
|
| Revenue as Reported | 8.33 | - | - | 9.75 | 11.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.